The drugmaker, along with partner Ridgeback Biotherapeutics, plan to ask the FDA for emergency authorization “as soon as possible.”
The drugmaker, along with partner Ridgeback Biotherapeutics, plan to ask the FDA for emergency authorization “as soon as possible.”
Copyright © 2024 | WordPress Theme by MH Themes